Logo Unión Europea

NANOFACTURING: Medium- and large-scale manufacturing platforms for clinically compliant nanopharmaceuticals

Development of medium- and large-scale sustainable manufacturing process platforms for clinically compliant solid core nanopharmaceuticals

GalChimia, Applus+ Laboratories, Midatech, Prochimia, the Centre for Process Innovation (CPI), and three Academic groups have participated in the research project entitled “NanoFacturing – The Development of Medium- and Large-Scale Sustainable Manufacturing Process Platforms for Clinically Compliant Solid Core Nanopharmaceuticals”.

The main objective of the project is to develop a new manufacturing platform process for solid core nanopharmaceutical products, capable of being scaled up to supply Phase III trials and beyond, which is cost-effective, safe, efficient, robust, and regulatory compliant. GalChimia has been specifically involved in the synthesis of the ligands used to bind the nanoparticles to other chemical or biological molecules. The project has been financed by the European Union through the Horizon 2020 programme.

Check the results of the Nanofacturing project

Nanofacturing Logo
Logo Galchimia letters

Subscribe to stay updated on the latest advances in organic synthesis and GalChimia’s good chemistry

     "*" mandatory

    I agree, and accept the data protection policy